Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03843957 · ClinicalTrials.gov registry record · NA
Effectiveness and Implementation of mPATH-CRC
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 77,145
- Enrollment target
NCT03843957: Completed NA study, sponsored by Wake Forest University Health Sciences.
NCT03843957 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 77,145 participants, above the 1,402-participant average among 58,714 other NA trials with a reported enrollment target (5402% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03843957, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 77,145 participants
- Enrollment target
Study Summary
Study Investigators are conducting this study to learn how to best implement a new iPad program in clinical practice.
Primary Outcome
mPATH-CRC Implementation: Percent of all eligible patients, ages 50 - 74, who complete the mPATH-CRC program in the 6th month following the implementation date.
Interventions
- OTHER mPATH-CRC
- OTHER mPATH-Checkin
- OTHER "high touch" Implementation strategy
- OTHER "low touch" Implementation Strategy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77,145 participants |
| Start Date | 2019-10-31 |
| Est. Completion | 2023-03-10 |
| Phase | NA |
What the finished NCT03843957 record still lists
NCT03843957 is an interventional study that assigns participants to a tested intervention. Its 77,145 participants enrollment target places it among the larger protocols in the corpus, above the 1,402-participant average among 58,714 other NA trials with a reported enrollment target (5402% higher).
The record links to 0 conditions, and to 4 interventions - of which mPATH-CRC is the first listed.
NCT03843957 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03843957 about?
NCT03843957 is a clinical study titled "Effectiveness and Implementation of mPATH-CRC". Study Investigators are conducting this study to learn how to best implement a new iPad program in clinical practice.
What is the current status of trial NCT03843957?
This trial is currently completed. It is a NA study. The enrollment target is 77,145 participants. The study started on 2019-10-31. Estimated completion is 2023-03-10.
What interventions are being tested in trial NCT03843957?
The interventions under investigation include: mPATH-CRC (OTHER), mPATH-Checkin (OTHER), "high touch" Implementation strategy (OTHER), "low touch" Implementation Strategy (OTHER).
Who is sponsoring clinical trial NCT03843957?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03843957's enrollment target sits among peer trials
77,145 4th of 2000 higher than 1,997 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02402244 · 75,000 participants
Project: Every Child for Younger Patients With Cancer
- NCT02803242 · 75,000 participants
COPD Patient-Powered Research Network
- NCT04611568 · 75,000 participants · NA
War on Melanoma™ Public Health & Education Campaign
- NCT00063063 · 80,000 participants
Generic Database of Very Low Birth Weight Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI